Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T87325 | Target Info | |||
Target Name | COVID-19 papain-like proteinase (PL-PRO) | ||||
Synonyms | COVID-19 papain-like proteinase; COVID-19 PL2-PRO; COVID-19 PL-PRO; COVID-19 main proteinase; COVID-19 non-structural protein 3 | ||||
Gene Name | COVID-19 rep; COVID-19 1a-1b | ||||
Biochemical Class | Coronaviruses polyprotein 1ab family | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Adenosine-5-diphosphoribose | Ligand Info | |||
Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)O)O)O)O)O)N | ||||
InChI | 1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1 | ||||
InChIKey | SRNWOUGRCWSEMX-ZQSHOCFMSA-N | ||||
PubChem Compound ID | 447048 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6Z5T SARS-CoV-2 Macrodomain in complex with ADP-ribose | ||||||
Method | X-ray diffraction | Resolution | 1.57 Å | Mutation | No | [1] |
PDB Sequence |
EVNSFSGYLK
215 LTDNVYIKNA225 DIVEEAKKVK235 PTVVVNAANV245 YLKHGGGVAG255 ALNKATNNAM 265 QVESDDYIAT275 NGPLKVGGSC285 VLSGHNLAKH295 CLHVVGPNVN305 KGEDIQLLKS 315 AYENFNQHEV325 LLAPLLSAGI335 FGADPIHSLR345 VCVDTVRTNV355 YLAVFDKNLY 365 DKLVSSFLEM375 KSEK
|
|||||
|
ALA225
4.000
ASP226
2.837
ILE227
2.948
VAL228
4.953
ALA242
3.510
ALA243
4.069
ASN244
2.810
LYS248
3.195
HIS249
3.645
GLY250
2.950
GLY251
3.509
GLY252
2.895
VAL253
2.790
ALA254
3.616
GLY255
4.365
|
|||||
PDB ID: 6WOJ Structure of the SARS-CoV-2 macrodomain (NSP3) in complex with ADP-ribose | ||||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [2] |
PDB Sequence |
VNSFSGYLKL
12 TDNVYIKNAD22 IVEEAKKVKP32 TVVVNAANVY42 LKHGGGVAGA52 LNKATNNAMQ 62 VESDDYIATN72 GPLKVGGSCV82 LSGHNLAKHC92 LHVVGPNVNK102 GEDIQLLKSA 112 YENFNQHEVL122 LAPLLSAGIF132 GADPIHSLRV142 CVDTVRTNVY152 LAVFDKNLYD 162 KLVSSFLEM
|
|||||
|
ALA21
4.017
ASP22
2.938
ILE23
3.039
VAL24
4.959
ALA38
3.486
ALA39
4.130
ASN40
2.767
LYS44
3.122
HIS45
3.799
GLY46
3.234
GLY47
3.339
GLY48
2.989
VAL49
2.786
ALA50
3.471
GLY51
4.246
|
|||||
PDB ID: 6YWL Crystal structure of SARS-CoV-2 (Covid-19) NSP3 macrodomain in complex with ADP-ribose | ||||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [3] |
PDB Sequence |
GHMVNSFSGY
9 LKLTDNVYIK19 NADIVEEAKK29 VKPTVVVNAA39 NVYLKHGGGV49 AGALNKATNN 59 AMQVESDDYI69 ATNGPLKVGG79 SCVLSGHNLA89 KHCLHVVGPN99 VNKGEDIQLL 109 KSAYENFNQH119 EVLLAPLLSA129 GIFGADPIHS139 LRVCVDTVRT149 NVYLAVFDKN 159 LYDKLVSSFL169 EM
|
|||||
|
ALA21
3.758
ASP22
2.737
ILE23
3.017
VAL24
4.932
ALA38
3.475
ALA39
4.013
ASN40
2.844
LYS44
3.033
HIS45
3.706
GLY46
3.258
GLY47
2.397
GLY48
3.420
VAL49
2.798
ALA50
3.451
GLY51
4.479
|
|||||
PDB ID: 6W02 Crystal Structure of ADP ribose phosphatase of NSP3 from SARS CoV-2 in the complex with ADP ribose | ||||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | No | [4] |
PDB Sequence |
NSFSGYLKLT
13 DNVYIKNADI23 VEEAKKVKPT33 VVVNAANVYL43 KHGGGVAGAL53 NKATNNAMQV 63 ESDDYIATNG73 PLKVGGSCVL83 SGHNLAKHCL93 HVVGPNVNKG103 EDIQLLKSAY 113 ENFNQHEVLL123 APLLSAGIFG133 ADPIHSLRVC143 VDTVRTNVYL153 AVFDKNLYDK 163 LVSSF
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .APR or .APR2 or .APR3 or :3APR;style chemicals stick;color identity;select .A:21 or .A:22 or .A:23 or .A:24 or .A:38 or .A:39 or .A:40 or .A:44 or .A:45 or .A:46 or .A:47 or .A:48 or .A:49 or .A:50 or .A:51 or .A:52 or .A:125 or .A:126 or .A:127 or .A:128 or .A:129 or .A:130 or .A:131 or .A:132 or .A:133 or .A:154 or .A:155 or .A:156 or .A:157 or .A:160; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ALA21
3.704
ASP22
2.919
ILE23
2.933
VAL24
4.933
ALA38
3.431
ALA39
4.074
ASN40
2.948
LYS44
2.984
HIS45
3.754
GLY46
2.973
GLY47
3.414
GLY48
2.914
VAL49
2.780
ALA50
3.734
GLY51
4.561
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biol. 2020 Nov;10(11):200237. | ||||
REF 2 | The SARS-CoV-2 Conserved Macrodomain Is a Mono-ADP-Ribosylhydrolase. J Virol. 2021 Jan 13;95(3):e01969-20. | ||||
REF 3 | Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain. ACS Med Chem Lett. 2021 Mar 16;12(4):603-609. | ||||
REF 4 | Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes. IUCrJ. 2020 Jul 17;7(Pt 5):814-824. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.